Back to Search Start Over

Hemiarthroplasty compared to internal fixation with percutaneous cannulated screws as treatment of displaced femoral neck fractures in the elderly: cost-utility analysis performed alongside a randomized, controlled trial.

Authors :
Waaler Bjørnelv, G.
Frihagen, F.
Madsen, J.
Nordsletten, L.
Aas, E.
Source :
Osteoporosis International. Jun2012, Vol. 23 Issue 6, p1711-1719. 9p. 4 Charts, 1 Graph.
Publication Year :
2012

Abstract

Summary: We estimated the cost-effectiveness of hemiarthroplasty compared to internal fixation for elderly patients with displaced femoral neck fractures. Over 2 years, patients treated with hemiarthroplasty gained more quality-adjusted life years than patients treated with internal fixation. In addition, costs for hemiarthroplasty were lower. Hemiarthroplasty was thus cost effective. Introduction: Estimating the cost utility of hemiarthroplasty compared to internal fixation in the treatment of displaced femoral neck fractures in the elderly. Methods: A cost-utility analysis (CUA) was conducted alongside a clinical randomized controlled trial at a university hospital in Norway; 166 patients, 124 (75%) women with a mean age of 82 years were randomized to either internal fixation ( n = 86) or hemiarthroplasty ( n = 80). Patients were followed up at 4, 12, and 24 months. Health-related quality of life was assessed with the EQ-5D, and in combination with time used to calculate patients' quality-adjusted life years (QALYs). Resource use was identified, quantified, and valued for direct and indirect hospital costs and for societal costs. Results were expressed in incremental cost-effectiveness ratios. Results: Over the 2-year period, patients treated with hemiarthroplasty gained 0.15-0.20 more QALYs than patients treated with internal fixation. For the hemiarthroplasty group, the direct hospital costs, total hospital costs, and total costs were non-significantly less costly compared with the internal fixation group, with an incremental cost of €2,731 ( p = 0.81), €2,474 ( p = 0.80), and €14,160 ( p = 0.07), respectively. Thus, hemiarthroplasty was the dominant treatment. Sensitivity analyses by bootstrapping supported these findings. Conclusion: Hemiarthroplasty was a cost-effective treatment. Trial registration, NCT00464230. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0937941X
Volume :
23
Issue :
6
Database :
Academic Search Index
Journal :
Osteoporosis International
Publication Type :
Academic Journal
Accession number :
75231528
Full Text :
https://doi.org/10.1007/s00198-011-1772-1